Betrixaban for VTE Prevention in the Medically Ill Population, the APEX Trial: Good News for This Needy Population?

Clin Appl Thromb Hemost. 2017 Oct;23(7):701-702. doi: 10.1177/1076029616683805. Epub 2016 Dec 18.

Authors

Eduardo Ramacciotti^{1

2}, Debra Hoppensteadt², Jawed Fareed²

Affiliations

¹ 1 Hospital e Maternidade Dr Christóvão da Gama, Santo André, SP, Brazil.
² 2 Department of Pathology, Loyola University Chicago, Maywood, IL, USA.

PMID: 28294628
DOI: 10.1177/1076029616683805

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use
Benzamides / therapeutic use*
Clinical Trials as Topic
Humans
Pyridines / therapeutic use*
Venous Thromboembolism / prevention & control*

Substances

Anticoagulants
Benzamides
Pyridines
betrixaban